SOPHiA GENETICS reaffirms $72M–$76M 2025 revenue guidance as AstraZeneca deal drives BioPharma outlook SOPHiA GENETICS reaffirms $72M–$76M 2025 revenue guidance as AstraZeneca deal drives BioPharma outlook Post ContentsophRead More You might also be interested in reading Here’s why Zcash price rallied over 20% today. August 6, 2025 In Mainstream ← Previous post Next post →